"JR's depth across corporate development, portfolio strategy, and private equity environments is a strong fit for where Conexeu is headed, " said Jeff Sharpe, Chairman of the Board. "We're building an ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

StimLabs, a leading regenerative medicine company, announced the launch of Architect Fx, an innovative extracellular collagen matrix derived from equine pericardium for wound management.

Researchers say study findings have highlighted biomarkers that could help improve early diagnosis of esophageal cancer, when it is easier to treat.

Why Bone Fractures Are Increasing. You likely have, at the very least, known someone who has broken a bone in their lifetime. While these experiences can range from childhood acci ...

Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation extracellular ...

癌症相关成纤维细胞（CAF）在塑造肿瘤微环境（TME）和驱动肿瘤进展中发挥着关键作用。尽管单细胞转录组学已揭示了CAF的表型和功能异质性，但针对CAF的有效治疗策略仍亟待开发。

先天性心脏病是最常见的新生儿出生缺陷，全球发病率约为0.6-1.2%，其中约60%的病例需要干预治疗。目前，微创经导管封堵器植入术已成为治疗房间隔缺损、室间隔缺损等先天性心脏缺陷的主要手段。然而，临床实践中封堵器植入仍面临着重大的挑战：材料相对不足的 ...